Article

(2021) Design of a chitosan-based nano vaccine against epsilon toxin of Clostridium perfringens type D and evaluation of its immunogenicity in BALB/c mice. Research in Pharmaceutical Sciences. pp. 575-585. ISSN 1735-5362

(2021) Designing and determining immunogenicity of a recombinant protein due to producing a new vaccine against Enterotoxigenic Escherichia coli containing CfaE and CotD subunits. J Immunoassay Immunochem. pp. 525-542. ISSN 1532-1819

(2021) The design and production of engineered sta toxin as a vaccine candidate against enterotoxigenic Escherichia coli. Journal of Applied Biotechnology Reports. pp. 27-31. ISSN 23221186 (ISSN)

(2020) Immunogenicity Evaluation of Chimeric Subunit Vaccine Comprising Adhesion Coli Surface Antigens from Enterotoxigenic Escherichia coli. Journal of Molecular Microbiology and Biotechnology. pp. 91-100. ISSN 1464-1801

(2020) The Immunogenicity of a Novel Chimeric Hemagglutinin-Neuraminidase-Fusion Antigen from Newcastle Disease Virus by Oral Delivery of Transgenic Canola Seeds to Chickens. Molecular Biotechnology. pp. 344-354. ISSN 1073-6085

(2019) Construction and Structural Assessment of Nanocapsule Containing HER2-MUC1 Chimeric Protein as a Candidate for a Vaccine Against Breast Cancer. International Journal of Cancer Management. p. 8. ISSN 2538-4422

(2019) Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein. Microbial Pathogenesis. p. 6. ISSN 0882-4010

(2019) Immunogenic Evaluation of Bivalent Vaccine Candidate against Enterohemorrhagic and Enterotoxigenic Escherichia coli. Iranian Journal of Immunology. pp. 200-211. ISSN 1735-1383

(2019) Immunogenicity Evaluation of Chimeric Subunit Vaccine Comprising Adhesion Coli Surface Antigens from Enterotoxigenic Escherichia coli. J Mol Microbiol Biotechnol. pp. 91-100. ISSN 1464-1801

(2018) Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications. Iranian Journal of Biotechnology. pp. 248-257. ISSN 1728-3043

(2018) Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice. Clinical and Experimental Vaccine Research. pp. 51-60. ISSN 2287-3651

(2016) Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins. Microbes and Infection. pp. 421-429. ISSN 1286-4579

(2014) In Silico Design of Multimeric HN-F Antigen as a Highly Immunogenic Peptide Vaccine Against Newcastle Disease Virus. International Journal of Peptide Research and Therapeutics. pp. 179-194. ISSN 1573-3149